Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 29, 2010CirculationOpen Access

Predicting Survival in Pulmonary Arterial Hypertension

View Full Paper
Ask AI
Bookmark
Share

Why the study?

What are the independent predictors of 1-year survival in patients with pulmonary arterial hypertension?

Population

2716 patients with pulmonary arterial hypertension enrolled consecutively in the US Registry to Evaluate…

Design

Cohort

Follow-up

1 year

Authors

Raymond L. BenzaRaymond L. BenzaVascular / Pulmonary VascularDMDave P. MillerStanford Health CareMardi Gomberg‐MaitlandMardi Gomberg‐MaitlandHeart Failure & Transplant

Discussion

Loading...

Member takes

Implication

Supports PAH risk stratification; leaves open prospective validation of the derived formula before guiding therapy.

Key Points

  • To identify independent predictors of 1-year survival in patients with pulmonary arterial hypertension and derive a multivariable, weighted risk prediction formula for clinical use.
  • Interventional registry study evaluating consecutive participants with pulmonary arterial hypertension enrolled in the US REVEAL registry (N=2716; NCT00370214).
  • Multivariable Cox proportional hazards regression and bootstrap validation were conducted using clinical, hemodynamic, and laboratory evaluations to formulate a survival prediction equation.
  • Overall 1-year survival from registry enrollment was 91.0% (95% CI, 89.9 to 92.1).
  • Mortality was independently predicted by pulmonary vascular resistance >32 Wood units (HR, 4.1; 95% CI, 2.0 to 8.3), portal hypertension (HR, 3.6; 95% CI, 2.4 to 5.4), and functional class IV symptoms (HR, 3.1; 95% CI, 2.2 to 4.4).
  • Male sex over age 60 (HR, 2.2; 95% CI, 1.6 to 3.0) and family history of pulmonary arterial hypertension (HR, 2.2; 95% CI, 1.2 to 4.0) also independently predicted increased mortality.

Structured PICO

What are the independent predictors of 1-year survival in patients with pulmonary arterial hypertension?

P
Population
2716 patients with pulmonary arterial hypertension (PAH) enrolled consecutively in the US Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
O
Outcome
1-year survivalhard clinical

A multivariable prognostic equation derived from the REVEAL registry identifies key predictors of 1-year survival in PAH to help individualize therapeutic strategies.

Cite This Study

Benza et al. (2010) studied this question.

synapsesocial.com/papers/69f29cf91b51e2fbf0187325https://doi.org/10.1161/circulationaha.109.898122
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Survival in Patients with Primary Pulmonary Hypertension1991 · 3,525 citations
  2. 2Hemodynamics and Survival of Patients With Portopulmonary Hypertension2005 · 160 citations
  3. 3Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension2008 · 132 citations
  4. 4The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension1992 · 1,559 citations
  5. 5Clinical classification of pulmonary hypertension2004 · 1,901 citations